Literature DB >> 27751823

Punctate inner choroidopathy: A review.

Dana Ahnood1, Savitha Madhusudhan2, Marie D Tsaloumas3, Nadia K Waheed4, Pearse A Keane5, Alastair K Denniston6.   

Abstract

Punctate inner choroidopathy (PIC), an idiopathic inflammatory multifocal chorioretinopathy that predominantly affects young myopic women, appears to be relatively rare, but there are limited data to support accurate estimates of prevalence, and it is likely that the condition is underdiagnosed. The etiological relationship between PIC and other conditions within the "white dot syndromes" group remains uncertain. We, like others, would suggest that PIC and multifocal choroiditis with panuveitis represent a single disease process that is modified by host factors (including host immunoregulation) to cause the range of clinical phenotypes seen. The impact of PIC on the patient is highly variable, with outcome ranging from complete spontaneous recovery to bilateral severe sight loss. Detection and monitoring have been greatly facilitated by modern scanning techniques, especially optical coherence tomography and autofluorescence imaging and may be enhanced by coregistration of sequential images to detect change over time. Depending on the course of disease and nature of complications, appropriate treatment may range from observation to systemic immunosuppression and antiangiogenic therapies. PIC is a challenging condition where treatment has to be tailored to the patient's individual circumstances, the extent of disease, and the risk of progression.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  choroidal neovascularization; posterior uveitis; punctate inner choroidopathy; white dot syndromes

Mesh:

Year:  2016        PMID: 27751823     DOI: 10.1016/j.survophthal.2016.10.003

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  16 in total

1.  Intra and inter-rater agreement of inflammatory choroidal neovascular membrane measurements using optical coherence tomography angiography.

Authors:  Inês Leal; Shi Zhuan Tan; Tariq Aslam; Laura R Steeples; Nicholas P Jones; Ramandeep Chhabra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-19       Impact factor: 3.117

2.  Outcomes of adalimumab therapy in refractory punctate inner choroidopathy and multifocal choroiditis.

Authors:  Or Shmueli; Radgonde Amer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-04       Impact factor: 3.117

3.  The efficacy of adalimumab in treating patients with central multifocal choroiditis.

Authors:  Evianne L de Groot; Jeannette Ossewaarde-van Norel; Lintje Ho; Ninette H Ten Dam-van Loon; Joke H de Boer
Journal:  Am J Ophthalmol Case Rep       Date:  2020-09-17

4.  Idiopathic multifocal choroiditis and punctate inner choroidopathy: an evaluation in pregnancy.

Authors:  Evianne L de Groot; Ramon A C van Huet; Kitty W M Bloemenkamp; Joke H de Boer; Jeannette Ossewaarde-van Norel
Journal:  Acta Ophthalmol       Date:  2021-05-19       Impact factor: 3.988

5.  Merging Information From Infrared and Autofluorescence Fundus Images for Monitoring of Chorioretinal Atrophic Lesions.

Authors:  Giovanni Ometto; Giovanni Montesano; Saman Sadeghi Afgeh; Georgios Lazaridis; Xiaoxuan Liu; Pearse A Keane; David P Crabb; Alastair K Denniston
Journal:  Transl Vis Sci Technol       Date:  2020-08-25       Impact factor: 3.283

6.  Swept Source-Optical Coherence Tomography Angiography for Management of Secondary Choroidal Neovascularization in Punctate Inner Choroidopathy.

Authors:  Martin Stattin; Julia Forster; Daniel Ahmed; Katharina Krepler; Siamak Ansari-Shahrezaei
Journal:  Case Rep Ophthalmol       Date:  2021-04-12

7.  Long-term results of intravitreal bevacizumab and dexamethasone for the treatment of punctate inner choroidopathy associated with choroidal neovascularization: A case series.

Authors:  Konstantinos T Tsaousis; Mohamed Nassr; Bharat Kapoor; Vasileios E Konidaris; Straton Tyradellis; Theo Empeslidis
Journal:  SAGE Open Med Case Rep       Date:  2018-05-06

8.  Treatment of Punctate Inner Choroidopathy with Choroidal Neovascularization Using Corticosteroid and Intravitreal Ranibizumab.

Authors:  Wei Wu; Shiying Li; Haiwei Xu; Yong Liu; Yi Wang; Timothy Y Y Lai; Zheng Qin Yin
Journal:  Biomed Res Int       Date:  2018-09-13       Impact factor: 3.411

Review 9.  An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management.

Authors:  Aniruddha Agarwal; Alessandro Invernizzi; Rohan Bir Singh; William Foulsham; Kanika Aggarwal; Sabia Handa; Rupesh Agrawal; Carlos Pavesio; Vishali Gupta
Journal:  J Ophthalmic Inflamm Infect       Date:  2018-09-12

10.  Inflammatory Choroidal Neovascular Membranes: Clinical Profile, Treatment Effectiveness, and Visual Prognosis.

Authors:  Gonçalo Carrola; Mário Lima-Fontes; Fernando Falcão-Reis; Luís Figueira; Ângela Carneiro
Journal:  J Ophthalmol       Date:  2021-07-23       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.